Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]

被引:0
|
作者
Strange, C.
Tkacz, J.
Schinkel, J.
机构
关键词
D O I
10.2147/COPD.S484253
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:1799 / 1799
页数:1
相关论文
共 50 条
  • [1] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256
  • [2] Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate
    Pollack, M.
    Tkacz, J. P.
    Schinkel, J.
    Lewing, B.
    Agatep, B.
    Swisher, S.
    Patel, S.
    Edwards, D.
    Touchette, D.
    Portillo, E.
    Feigler, N.
    Strange, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] CHARACTERISTICS OF EARLY ADOPTERS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL: A SINGLE-INHALER TRIPLE THERAPY FOR COPD
    Pollack, Michael
    Noorduyn, Stephen G.
    Lee, Inyoung
    Sun, Kainan K. S.
    Zhao, Xiaohui
    Kruse, Lisa K.
    Feigler, Norbert
    Patel, Sushma M.
    Near, Aimee
    CHEST, 2022, 162 (04) : 1887A - 1888A
  • [4] Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Ferguson, G. T.
    Wang, C.
    Singh, D.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    McLaren, J.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] REAL-WORLD ADHERENCE TO SINGLE-INHALER VS MULTIPLE-INHALER TRIPLE THERAPY AMONG PATIENTS WITH COPD IN A COMMERCIALLY INSURED US POPULATION
    Bogart, Michael
    Wu, Benjamin
    Germain, Guillaume
    Laliberte, Francois
    MacKnight, Sean
    Jung, Young
    Duh, Mei
    CHEST, 2020, 158 (04) : 1773A - 1774A
  • [6] Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity
    Eilat-Tsanani, Sophia
    Ernst, Pierre
    Suissa, Samy
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [7] Real-world efficacy of "fixed triple" single-inhaler combinations in COPD and asthma patients
    Mochizuki, Taichi
    Arai, Hiroyuki
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Umeda, Akira
    To, Yasuo
    Tsushima, Kenji
    RESPIROLOGY, 2023, 28 : 311 - 312
  • [8] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [9] HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY
    Pollack, Michael
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel
    Portillo, Edward C.
    Feigler, Norbert
    Strange, Charlie
    CHEST, 2023, 164 (04) : 4969A - 4970A
  • [10] REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US
    McCormack, Meredith C.
    Noorduyn, Stephen G.
    Gronroos, Noelle
    Lee, Lydia
    Johnson, Mary
    Wrobleski, Kristin
    Veeranki, Phani
    Ismaila, Afisi S.
    Igboekwe, Emmeline
    Paczkowski, Rosirene
    CHEST, 2023, 164 (04) : 4942A - 4943A